← Back to Search

Behavioral Intervention

Financial Incentives for Colorectal Cancer Screening (BENEFIT-C Trial)

N/A
Waitlist Available
Led By Marie A Krousel-Wood, MD, MSPH
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 45 to 75
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

BENEFIT-C Trial Summary

This trial will test if offering financial incentives to primary care patients to get colorectal cancer screening increases completion rates. It will also look at if incentives for colorectal cancer screening and other vaccines increases completion of all three.

Who is the study for?
This trial is for individuals aged 45 to 75 who receive care at a participating primary care clinic and are due for colorectal cancer screening. They must be able to understand and speak English.Check my eligibility
What is being tested?
The study tests if financial incentives can increase the rate of colorectal cancer screenings, flu shots, and COVID-19 vaccinations. Participants will either get an incentive for just the vaccines or both the vaccines and the cancer screening.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves financial incentives rather than medical treatments.

BENEFIT-C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 45 and 75 years old.

BENEFIT-C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two months
This trial's timeline: 3 weeks for screening, Varies for treatment, and two months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in proportion of participants completing colorectal cancer screening between study arms
Secondary outcome measures
Difference in proportion of participants completing COVID-19 shot between study arms
Difference in proportion of participants completing all three services between study arms: colorectal cancer screening, COVID-19 shot, flu shot
Difference in proportion of participants completing at least one of the following services between study arms: colorectal cancer screening, COVID-19 shot, flu shot
+1 more
Other outcome measures
Number of patients approached for recruitment
Number of patients assessed for eligibility
Number of patients randomized
+1 more

BENEFIT-C Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Full financial incentivesExperimental Treatment3 Interventions
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening
Group II: Partial financial incentivesActive Control2 Interventions
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Financial incentive for COVID-19 shot
2023
N/A
~50
Financial incentive for flu shot
2023
N/A
~50
Financial incentive for colorectal cancer screening
2023
N/A
~50

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,186 Total Patients Enrolled
7 Trials studying Health Behaviors
882 Patients Enrolled for Health Behaviors
Tulane UniversityLead Sponsor
117 Previous Clinical Trials
237,575 Total Patients Enrolled
3 Trials studying Health Behaviors
1,094 Patients Enrolled for Health Behaviors
Marie A Krousel-Wood, MD, MSPHPrincipal InvestigatorTulane University
1 Previous Clinical Trials
402 Total Patients Enrolled
~33 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top